NDC codes

FDA NDC Directory
Product NDC (as listed)60923-507Labeler and product segments. Claims need a package NDC.
Product NDC at billing width60923-0507Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
60923-507-16609230507161 KIT in 1 CARTON (60923-507-16) * 10 mL in 1 VIAL, SINGLE-USE (60923-562-01) * 16 POUCH in 1 BOX / 1 SWAB in 1 POUCHMarketed from Jun 22, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Elevidys
Generic name (nonproprietary)
delandistrogene moxeparvovec-rokl
Dosage form
Kit
Route
Intravenous
Labeler
Sarepta Therapeutics, Inc.NDC labeler code 60923
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 125781
Marketing start
Listing expires
Identifiers
Product ID 60923-507_a96a4f2b-47a9-4175-b3c4-78a0c9350a09SPL ID a96a4f2b-47a9-4175-b3c4-78a0c9350a09SPL set ID 3525abcd-fbd2-46c5-9706-cffdf2e8a361RxCUI 797544, 2641679, 2641685, 2641687, 2641688, 2641689, 2641690, 2641691, 2641692, 2641693, 2641694, 2641695, 2641696, 2641697, 2641698, 2641699, 2641700, 2641701, 2641702, 2641703, 2641704, 2641705, 2641706, 2641707, 2641708, 2641709, 2641710, 2641711, 2641712, 2641713, 2641714, 2641715, 2641716, 2641717, 2641718, 2641719, 2641720, 2641721, 2641722, 2641723, 2641724, 2641725, 2641726, 2641727, 2641728, 2641729, 2641730, 2641731, 2641732, 2641733, 2641734, 2641735, 2641736, 2641737, 2641738, 2641739, 2641740, 2641741, 2641742, 2641743, 2641744, 2641745, 2641746, 2641747, 2641748, 2641750, 2641751, 2641752, 2641753, 2641754, 2641755, 2641756, 2641757, 2641758, 2641759, 2641760, 2641761, 2641762, 2641763, 2641764, 2641765, 2641766, 2641767, 2641768, 2641769, 2641770, 2641771, 2641772, 2641773, 2641774, 2641775, 2641776, 2641777, 2641778, 2641779, 2641780, 2641781, 2641782, 2641783, 2641784, 2641785, 2641786, 2641787, 2641788, 2641789, 2641830, 2641831, 2641832, 2641833, 2641834, 2641835, 2641836, 2641837, 2641838, 2641839, 2641840, 2641841, 2641842, 2641843, 2641844, 2641845, 2641846, 2641847, 2641848, 2641849UPC 0360923501108, 0360923528372, 0360923540497, 0360923521304, 0360923509180, 0360923542514, 0360923541500, 0360923526354, 0360923559680, 0360923544532, 0360923536452, 0360923525340, 0360923547564, 0360923537466, 0360923503126, 0360923502112, 0360923533420, 0360923505144, 0360923514238, 0360923519288, 0360923529386, 0360923550595, 0360923518274, 0360923517260, 0360923527368, 0360923522318, 0360923515242, 0360923553626, 0360923520291, 0360923512210, 0360923555644, 0360923546550, 0360923551608, 0360923524336, 0360923561706, 0360923552612, 0360923513224, 0360923530399, 0360923554630, 0360923543528, 0360923534434, 0360923504130, 0360923548578, 0360923511206, 0360923510193, 0360923507162, 0360923532416, 0360923557662, 0360923535448, 0360923539484, 0360923538470, 0360923549582, 0360923506158, 0360923556658, 0360923545546, 0360923516256, 0360923560693, 0360923558676, 0360923508176, 0360923531402, 0360923523322

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N460923050716 followed by a unit qualifier and the quantity

Package 60923-0507-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

ELEVIDYS is indicated for the treatment of patients 4 years of age and older with Duchenne muscular dystrophy (DMD), who are ambulatory and have a confirmed mutation in the DMD gene [see Clinical Pharmacology ( 12.2 ), Clinical Studies ( 14 )] . ELEVIDYS is an adeno-associated virus vector-based gene therapy indicated for the treatment of patients 4 years of age and older with Duchenne muscular dystrophy (DMD) who are ambulatory and have a confirmed mutation in the DMD gene. ( 1 , 12.2 , 14 ) Limitations of Use: ELEVIDYS is not recommended in patients with: Preexisting liver impairment (defined as gamma-glutamyl transferase [GGT] > 2 x upper limit of normal or total bilirubin > the upper lim…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 60923-507

What is NDC 60923-507?
60923-507 is the product NDC for Elevidys (delandistrogene moxeparvovec-rokl) kit, listed with the FDA by Sarepta Therapeutics, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Elevidys (Delandistrogene moxeparvovec-rokl).
Who is the labeler?
Sarepta Therapeutics, Inc., NDC labeler code 60923. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Elevidys?
60 other product NDCs are listed under this name. See all Elevidys NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Elevidys NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-50660923-0506-15
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-50460923-0504-13
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-50560923-0505-14
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-51060923-0510-19
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-50860923-0508-17
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-50960923-0509-18
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-51160923-0511-20
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-51260923-0512-21
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-51360923-0513-22
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-51760923-0517-26

All 61 Elevidys NDCs

Other NDCs under BLA 125781

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 125781
ProductStrengthForm · routeLabelerProduct NDC
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-506
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-504
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-505
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-510
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-508
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-509
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-511
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-512
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-513
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-517
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-514
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-515
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-516
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-521
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-518
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-519
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-520
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-524
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-522
Elevidysdelandistrogene moxeparvovec-rokl—KitIntravenousSarepta Therapeutics, Inc.60923-523

Showing 20 of 39.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in